WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-08 08:36 am Sale |
2021-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 250,219 0.340% |
-7,352,526 (-96.71%) |
Filing |
| 2021-04-12 08:02 am Purchase |
2021-03-31 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 7,602,745 11.660% |
1,993,118 (+35.53%) |
Filing |
| 2021-02-03 1:22 pm Purchase |
2020-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 5,609,627 8.770% |
2,432,090 (+76.54%) |
Filing |